AAF
TEVA icon

Andra AP-fonden’s Teva Pharmaceuticals TEVA Stock Holding History

Andra AP-fonden’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,279,900
Closed -$11.3M – 600
2023
Q1 		$11.3M Buy
1,279,900
+519,700
+68% +$5.14M 0.29% 66
2022
Q4 		$6.93M Buy
760,200
+376,100
+98% +$3.28M 0.21% 189
2022
Q3 		$3.1M Sell
384,100
-155,600
-29% -$1.38M 0.1% 404
2022
Q2 		$4.06M Buy
+539,700
New +$4.7M 0.12% 393
2021
Q4 		$7.78M Buy
970,900
+552,200
+132% +$4.98M 0.16% 306
2021
Q3 		$4.08M Sell
418,700
-254,500
-38% -$2.38M 0.08% 475
2021
Q2 		$6.67M Sell
673,200
-15,700
-2% -$166K 0.14% 365
2021
Q1 		$7.95M Buy
688,900
+50,700
+8% +$581K 0.18% 266
2020
Q4 		$6.16M Buy
638,200
+372,600
+140% +$3.57M 0.14% 375
2020
Q3 		$2.39M Sell
265,600
-243,500
-48% -$2.58M 0.06% 547
2020
Q2 		$6.28M Buy
509,100
+87,800
+21% +$993K 0.18% 210
2020
Q1 		$3.78M Sell
421,300
-59,900
-12% -$614K 0.14% 383
2019
Q4 		$4.72M Buy
481,200
+100,200
+26% +$895K 0.13% 417
2019
Q3 		$2.62M Sell
381,000
-206,900
-35% -$1.59M 0.08% 568
2019
Q2 		$5.43M Buy
587,900
+189,300
+47% +$2.28M 0.16% 321
2019
Q1 		$6.25M Buy
+398,600
New +$7.03M 0.18% 219
2018
Q3 		$7.74M Buy
359,200
+213,700
+147% +$4.96M 0.2% 176
2018
Q2 		$3.54M Sell
145,500
-99,700
-41% -$2.03M 0.1% 515
2018
Q1 		$4.19M Buy
245,200
+172,200
+236% +$3.36M 0.11% 491
2017
Q4 		$1.38M Buy
73,000
+60,900
+503% +$916K 0.03% 626
2017
Q3 		$213K Sell
12,100
-4,700
-28% -$106K 0.01% 660
2017
Q2 		$558K Sell
16,800
-72,300
-81% -$2.24M 0.01% 654
2017
Q1 		$2.86K Sell
89,100
-12,600
-12% -$430K 0.07% 417
2016
Q4 		$3.69M Buy
+101,700
New +$4.06M 0.1% 328

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Andra AP-fonden's TEVA Position: Q2 2023 in Review

Andra AP-fonden sold out of Teva Pharmaceuticals (TEVA) in Q2 2023, closing a stake of 1,279,900 shares — an estimated $11.3M sold.

Andra AP-fonden first reported a position in TEVA in Q4 2016 and held it in 24 quarters. The position peaked at $11.3M in Q1 2023. 428 funds tracked by Wall St. Rank hold TEVA as of Q2 2023.

  • Andra AP-fonden reported no remaining Teva Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Andra AP-fonden sold 1,279,900 Teva Pharmaceuticals shares in Q2 2023, an estimated $11.3M.
  • Andra AP-fonden first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 24 quarters.
  • Andra AP-fonden's Teva Pharmaceuticals position peaked at $11.3M in Q1 2023.
  • 428 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2023.

Based on Andra AP-fonden's 13F filing for Q2 2023, filed 9 Aug 2023.